SCHEMBL4384874

SCHEMBL4384874

COCCc1c(Br)c(OCOC)cc(OCOC)c1-c1cccc(C=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.35
MAOB P27338 3/20 0.35
BRD4 O60885 1/20 0.35
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
EGFR P00533 2/20 0.33
FDPS P14324 1/20 0.33
PTGER4 P35408 1/20 0.33
MAPT P10636 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
TRIM24 O15164 1/20 0.30
TRIM33 Q9UPN9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864914 0.83 EGFR (0.37) SMN1; SMN2EGFRMAPTNPC1RAB9A
SCHEMBL4386967 0.83 CLK4 (0.37) MAOBALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL4386573 0.82 ALDH1A1 (0.36) BRD4ALDH1A1SMN1; SMN2EGFRFDPS
SCHEMBL4394964 0.81 EGFR (0.43) EGFRLMNA
SCHEMBL4385704 0.81 FYN (0.43) EGFR
SCHEMBL4385708 0.80 HDAC3 (0.38) MAOAMAOBBRD4EGFRFDPS
SCHEMBL4381550 0.79 BRD4 (0.34) MAOAMAOBBRD4ALDH1A1SMN1; SMN2
SCHEMBL4384793 0.78 EGFR (0.35) ALDH1A1SMN1; SMN2EGFRMAPTTDP1
SCHEMBL4379783 0.76 EGFR (0.36) ALDH1A1SMN1; SMN2EGFRMAPTNPC1
SCHEMBL4386995 0.76 EGFR (0.36) EGFRMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P MAOA 4162/4885MAOB 3920/4885BRD4 239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.